Controlled Substances Board (CSB)
Administrative Code Chapter Affected:
Ch. CSB 4 (Revised)
Related to: Designating Gabapentin as a monitored drug
Text: Text of SS 111-19
Comments for this Statement of Scope have closed
Related Permanent Rule: CR 20-080
Date Statement Approved by Governor: October 3, 2019
Date Statement Expires Under s. 227.135 (5), Stats.: May 4, 2022
| Date | Register | File |
|---|---|---|
| 11/4/2019 | 767A1, Statements of Scope | SS 111-19 |
| 12/30/2019 | 768B, Notices of Public Hearing and Comment Period for Statements of Scope | SS 111-19 Notice of Preliminary Hearing |
| 12/30/2019 | 768B, Notices of Public Hearing and Comment Period for Statements of Scope | SS 111-19 Scope Statement |
| 11/23/2020 | 779A4, Rule-Making Notices (Hearing Notices) | CR 20-080 Economic Impact Analysis |
| 11/23/2020 | 779A4, Rule-Making Notices (Hearing Notices) | CR 20-080 Rule Text |
| 11/23/2020 | 779A4, Rule-Making Notices (Hearing Notices) | CR 20-080 Hearing Information |
| 11/23/2020 | 779A4, Notices of Submittal of Proposed Rules to Legislative Council Clearinghouse | CR 20-080 |
| 3/29/2021 | 783B, Notices of Submittal of Rules to Legislature in Final Draft Form | CR 20-080 |
| 7/19/2021 | 787A3, Final Permanent Rules Filed with LRB for Administrative Code Publication | CR 20-080 Rule Text |
| 8/30/2021 | 788B, Final Rules Published in Administrative Code and Final Regulatory Flexibility Analyses | CR 20-080 Rule Text |
